TAKING AIM AT MELANOMA: Compounds kill melanoma cells by targeting oft-ignored part of cell cycle
The DOI matches its Crossref record.
Abstract
A CLASS OF SMALL MOLEcules called triphenylmethylamides (TPMAs) has been found to induce apoptosis (cell death) in melanoma cells ( J. Am. Chem. Soc. 2005, 127, 8686). The findings could point the way toward potential therapies for malignant melanoma, a particularly deadly form of skin cancer. Currently, a diagnosis of latestage melanoma is practically a death sentence. The average survival time for patients with such a diagnosis is only six months. Paul J. Hergenrother, an assistant professor of chemistry at the University of Illinois, Urbana-Champaign, decided to focus on melanoma after conversations with physicians. "I was really interested in the most untreatable forms of cancer," he says. "As I started reading up on [melanoma], I found that indeed there's only one clinically approved compound, and it has only a 2% efficacy in complete remission. There's really no good treatment." With their discovery of TPMAs, Hergenrother and his coworkers hope to change ...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
N-Methylation of Peptides: A New Perspective in Medicinal Chemistry
Chatterjee, J., Gilon, C., Hoffman, A., & Kessler, H. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000603 · Cited by 577
Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides
Agyei, D., & Danquah, M. K. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.01.001 · Cited by 355
Peptide therapeutics: Targeting the undruggable space
Tsomaia, N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.014 · Cited by 348
Chai, K. F., Voo, A. Y. H., & Chen, W. N. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12651 · Cited by 296
Metadata
- Authors
- HENRY, C.
- Venue
- Chemical & Engineering News Archive
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-06-20
- Volume
- 83
- Issue
- 25
- Pages
- 17
- ISSN
- 0009-2347 (ISSN-L)
- 2157-4936
- OpenAlex
- W78793067
- Cited by
- 55
- References
- 0
- Type
- other
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TAKING AIM AT MELANOMA: Compounds kill melanoma cells by targeting oft-ignored part of cell cycle. https://app.cochat.ai/papers/10.1021/cen-v083n025.p017
- The paper
- HENRY, C. (2005). TAKING AIM AT MELANOMA: Compounds kill melanoma cells by targeting oft-ignored part of cell cycle. Chemical & Engineering News Archive. https://doi.org/10.1021/cen-v083n025.p017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.